---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-019682"
form_type: "8-K"
ticker: "STTK"
cik: "0001680367"
company_name: "Shattuck Labs, Inc."
filed_at: "2026-01-22T23:59:59+00:00"
generated_at: "2026-05-16T08:47:27.563321+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Shattuck Labs enters $75M ATM equity distribution agreement with Leerink Partners

## Summary
- Entered Sales Agreement with Leerink Partners for at-the-market offering of up to $75M of common stock.
- Shares sold at market prices; company not obligated to sell any shares.
- Proceeds to fund ongoing/planned clinical trials and for working capital/general corporate purposes.
- Agent commission of up to 3% of gross sales price plus reimbursement of expenses.
- Registration statement on Form S-3 declared effective January 21, 2026; prospectus supplement filed January 22, 2026.

## SEC filing metadata
- accession: 0001193125-26-019682
- form_type: 8-K
- ticker: STTK
- cik: 0001680367
- company_name: Shattuck Labs, Inc.
- filed_at: 2026-01-22T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1680367/000119312526019682/0001193125-26-019682-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1680367/000119312526019682/d59331d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-019682
- JSON: https://secwatch.observer/filing/0001193125-26-019682.json
- Plain text: https://secwatch.observer/filing/0001193125-26-019682.txt

## Key facts
- Material Agreements
  Shattuck Labs, Inc. entered into Sales Agreement with Leerink Partners LLC valued at $75,000,000 (effective 2026-01-22).
  - Action: entry
  - Agreement: atm program
  - Counterparty: Leerink Partners LLC
  - Value: $75,000,000
  - Effective: 2026-01-22
  source text: On January 22, 2026, Shattuck Labs, Inc. (the “Company”) entered into a sales agreement (the “Sales Agreement”) with Leerink Partners LLC (the “Agent”), pursuant to which the Company may offer and sell from time to time shares of the Company’s common stock, $0.0001 par value per share (the “Shares”), through the Agent. The offering and sale of up to $75,000,000 of the Shares has been registered under the Securities Act of 1933, as amended (the “Securities Act”), pursuant to the Company’s Registration Statement on Form S-3 (File No. 333-292697) (the “Registration Statement”), which was originally filed with the Securities and Exchange Commission (“SEC”) on January 13, 2026 and declared effective by the SEC on January 21, 2026, the base prospectus contained within the Registration Statement, and a prospectus supplement that was filed with the SEC on January 22, 2026.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1680367/000119312526019682/0001193125-26-019682-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.